GenSight Biologics Market Cap

GenSight Biologics has a market cap or net worth of €34.20 million as of January 17, 2025. Its market cap has increased by 30.27% in one year.

Market Cap

34.20M

Enterprise Value

49.94M

Revenue

1.98M

Ranking

n/a

PE Ratio

n/a

Stock Price

€0.28

Market Cap Chart

Since July 13, 2016, GenSight Biologics's market cap has decreased from 252.15M to 34.20M, a decrease of -86.44%. That is a compound annual growth rate of -20.88%.

Market Cap History

Date	Market Cap	% Change
Jan 20, 2025	34.20M	3.46%
Dec 31, 2024	33.05M	28.79%
Dec 29, 2023	25.66M	-83.46%
Dec 30, 2022	155.20M	-39.23%
Dec 31, 2021	255.38M	-16.09%
Dec 31, 2020	304.35M	275.09%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Sanofi	123.34B
EssilorLuxottica Société anonyme	111.71B
Sartorius Stedim Biotech	19.50B
bioMérieux	13.05B
Ipsen	10.13B
Eurofins Scientific SE	8.99B
Virbac	2.58B
Ramsay Générale de Santé	1.35B

Market Cap Rankings